Newborn Bloodspot Sampling Guidelines March 2026
Warning
Main changes from previous version
- Information on the In Service Evaluation (ISE) for Spinal Muscular Atrophy (SMA)
that will be implemented from 23rd March 2026. - Healthcare professionals taking newborn bloodspot samples should ensure that parents are aware that SMA has been added to list of conditions screened for on a temporary, in-service evaluation basis
- The ISE will be for an 18-24 month period
All staff delivering the newborn screening programme should ensure they are aware of a these updated requirements/clarifications on taking samples, the management of repeat samples and the management of “movers in” and cross border babies.